Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries

217
55
Favorite

Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries

Benzinga2021-06-22

Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots. The company is ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

217

Report

Comment（55）

MitchellC
·2021-06-22
Read
Reply
Like
Report
IHo
·2021-06-22
Still waiting for it
Reply
Like
Report
MayTan
·2021-06-22
Great
Reply
1
Report
Fold Replies
- ngchris:
  Noted
  2021-06-30
  Reply
  Report
Tralala
·2021-06-22
Good
Reply
2
Report
Takiho
·2021-06-22
Looks good. Appreciate could I have a like too. Thanks
Reply
1
Report
Takiho
·2021-06-22
Hi looks bouncy
Reply
Like
Report
Harozzz
·2021-06-22
Nice move
Reply
1
Report
jyau73
·2021-06-22
Share going up once it start production..
Reply
Like
Report
Oddleo
·2021-06-22
Super!
Reply
1
Report
beeteh
·2021-06-22
Wow go go go! [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly]
Reply
2
Report
Fold Replies
- Enji4566:
  need comment tq
  2021-06-22
  Reply
  Report
AppleMango
·2021-06-22
Good expansion. Hopefully we don’t need the vaccines any more! Pls like n comments
Reply
2
Report
Fold Replies
- StayHome:
  Betting more vaccines needed in the comIng months or maybe years….
  2021-06-22
  Reply
  Report
angiesukardi
·2021-06-22
Wa
Reply
1
Report
Bluefish
·2021-06-22
Vaccines good
Reply
Like
Report
Jgoh
·2021-06-22
?
Reply
4
Report
Fold Replies
- Trollingck:
  h
  2021-06-22
  Reply
  Report
- Jgoh:
  ?
  2021-10-27
  Reply
  Report
peakaboo
·2021-06-22
The world need vaccine
Reply
6
Report
Fold Replies
- Oddleo:
  Yes You are right
  2021-06-22
  Reply
  Report
IsaacYap90
·2021-06-22
Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.
Reply
2
Report
ckong2013
·2021-06-22
Good
Reply
2
Report
Fold Replies
- IsaacYap90:
  Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.
  2021-06-22
  Reply
  Report
Claireeeee
·2021-06-22
haha
Reply
3
Report
Fold Replies
- IsaacYap90:
  Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.
  2021-06-22
  Reply
  Report
hobbitt
·2021-06-22
?
Reply
1
Report
Sheryl85
·2021-06-22
wow
Reply
5
Report
Fold Replies
- Sheryl85:
  [Cool]
  2021-06-22
  Reply
  Report
- Sheryl85:
  [Happy]
  2021-06-22
  Reply
  Report
- Acella:
  ?
  2021-06-22
  Reply
  Report
View more 2 comments

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2145031425?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-06-22 07:28","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2145031425","market":"us","top_or_hot":-1,"title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","media":"Benzinga","content":"<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","article_id":"2145031425","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","pubTimestamp":1624318087,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"Moderna计划将COVID-19疫苗产量扩大50%，包括助推器，供应其他国家","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9},"content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":129091441,"gmtCreate":1624341637983,"gmtModify":1703833979255,"author":{"id":"3586596115302871","authorId":"3586596115302871","name":"MitchellC","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3586596115302871","authorIdStr":"3586596115302871"},"htmlText":"Read","listText":"Read","text":"Read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129091441","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":120752870,"gmtCreate":1624339223490,"gmtModify":1703833925797,"author":{"id":"3576199681732017","authorId":"3576199681732017","name":"IHo","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3576199681732017","authorIdStr":"3576199681732017"},"htmlText":"Still waiting for it","listText":"Still waiting for it","text":"Still waiting for it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120752870","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":120271043,"gmtCreate":1624326256782,"gmtModify":1703833527971,"author":{"id":"3573019619191060","authorId":"3573019619191060","name":"MayTan","avatar":"https://static.tigerbbs.com/808e2dbe5d70103ebf181c1496a31644","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":3,"crmLevelSwitch":1,"idStr":"3573019619191060","authorIdStr":"3573019619191060"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/120271043","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5082169,"gmtCreate":1625063978965,"gmtModify":1663230342937,"authorId":3572005609122539,"author":{"id":3572005609122539,"idStr":"3572005609122539","authorId":3572005609122539,"name":"ngchris","avatar":"https://static.tigerbbs.com/76fa13deb76ef9b61305ed927b5c3290","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":120271043,"type":1,"supId":0,"prevId":0,"content":"<u>Noted</u>","text":"<u>Noted</u>","html":"<u>Noted</u>"}],"langContent":"EN"},{"id":120233673,"gmtCreate":1624324082892,"gmtModify":1703833430955,"author":{"id":"3586843995176207","authorId":"3586843995176207","name":"Tralala","avatar":"https://static.tigerbbs.com/743cb76c3b0c645ff52b7d65e0ce54bb","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3586843995176207","authorIdStr":"3586843995176207"},"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120233673","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":120203961,"gmtCreate":1624323432753,"gmtModify":1703833403358,"author":{"id":"3586588423230446","authorId":"3586588423230446","name":"Takiho","avatar":"https://static.tigerbbs.com/9c71ba836ffdebd7c9d6c75d4b188cd8","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3586588423230446","authorIdStr":"3586588423230446"},"htmlText":"Looks good.&nbsp;Appreciate could I have a like too. Thanks","listText":"Looks good.&nbsp;Appreciate could I have a like too. Thanks","text":"Looks good. Appreciate could I have a like too. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120203961","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":120674749,"gmtCreate":1624323325981,"gmtModify":1703833400420,"author":{"id":"3586588423230446","authorId":"3586588423230446","name":"Takiho","avatar":"https://static.tigerbbs.com/9c71ba836ffdebd7c9d6c75d4b188cd8","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3586588423230446","authorIdStr":"3586588423230446"},"htmlText":"Hi looks bouncy","listText":"Hi looks bouncy","text":"Hi looks bouncy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120674749","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":120671891,"gmtCreate":1624323140513,"gmtModify":1703833390065,"author":{"id":"3579862040038906","authorId":"3579862040038906","name":"Harozzz","avatar":"https://static.tigerbbs.com/9fe4ee8e38ad1b6b8db21f9d745af71a","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3579862040038906","authorIdStr":"3579862040038906"},"htmlText":"Nice move","listText":"Nice move","text":"Nice move","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120671891","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":120645147,"gmtCreate":1624322966989,"gmtModify":1703833382392,"author":{"id":"4087190501410390","authorId":"4087190501410390","name":"jyau73","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4087190501410390","authorIdStr":"4087190501410390"},"htmlText":"Share going up once it start production..","listText":"Share going up once it start production..","text":"Share going up once it start production..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120645147","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":120649347,"gmtCreate":1624322802089,"gmtModify":1703833374093,"author":{"id":"3582365143818595","authorId":"3582365143818595","name":"Oddleo","avatar":"https://static.tigerbbs.com/569e40b38ccc6665e8895b488137078c","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3582365143818595","authorIdStr":"3582365143818595"},"htmlText":"Super!","listText":"Super!","text":"Super!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120649347","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":120651789,"gmtCreate":1624322520242,"gmtModify":1703833362627,"author":{"id":"3581648035451607","authorId":"3581648035451607","name":"beeteh","avatar":"https://static.tigerbbs.com/960b8b03b4f897e711a5342ca856626e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581648035451607","authorIdStr":"3581648035451607"},"htmlText":"Wow go go go! [Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;","listText":"Wow go go go! [Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;[Sly]&nbsp;","text":"Wow go go go! [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly] [Sly]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/120651789","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4948961,"gmtCreate":1624332105013,"gmtModify":1663229685641,"authorId":3581545521821668,"author":{"id":3581545521821668,"idStr":"3581545521821668","authorId":3581545521821668,"name":"Enji4566","avatar":"https://static.tigerbbs.com/a959fafd643583915b167a78b5e55396","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":120651789,"type":1,"supId":0,"prevId":0,"content":"need comment <u>tq</u>","text":"need comment <u>tq</u>","html":"need comment <u>tq</u>"}],"langContent":"EN"},{"id":120612827,"gmtCreate":1624321383469,"gmtModify":1703833310429,"author":{"id":"3567141277226150","authorId":"3567141277226150","name":"AppleMango","avatar":"https://static.tigerbbs.com/68d3e430c230d4cfd4e97044c56f2b6d","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3567141277226150","authorIdStr":"3567141277226150"},"htmlText":"Good expansion. Hopefully we don’t need the vaccines any more! Pls like n comments&nbsp;","listText":"Good expansion. Hopefully we don’t need the vaccines any more! Pls like n comments&nbsp;","text":"Good expansion. Hopefully we don’t need the vaccines any more! Pls like n comments","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/120612827","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4944625,"gmtCreate":1624321836064,"gmtModify":1663229666244,"authorId":3586303845668227,"author":{"id":3586303845668227,"idStr":"3586303845668227","authorId":3586303845668227,"name":"StayHome","avatar":"https://static.tigerbbs.com/a2090cc80fca211990d8fc4e216f75b7","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":"60.95%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":120612827,"type":1,"supId":0,"prevId":0,"content":"Betting more vaccines needed in the comIng months or maybe years….","text":"Betting more vaccines needed in the comIng months or maybe years….","html":"Betting more vaccines needed in the comIng months or maybe years…."}],"langContent":"EN"},{"id":120634502,"gmtCreate":1624321160006,"gmtModify":1703833301371,"author":{"id":"3575449138931569","authorId":"3575449138931569","name":"angiesukardi","avatar":"https://static.tigerbbs.com/6c523d60efb391a234d53747478fb51f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3575449138931569","authorIdStr":"3575449138931569"},"htmlText":"Wa","listText":"Wa","text":"Wa","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120634502","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":120630914,"gmtCreate":1624320860438,"gmtModify":1703833289320,"author":{"id":"3574724399840291","authorId":"3574724399840291","name":"Bluefish","avatar":"https://community-static.tradeup.com/news/331df3ab3ccfe360e355f6cafc80b768","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":2,"crmLevelSwitch":1,"idStr":"3574724399840291","authorIdStr":"3574724399840291"},"htmlText":"Vaccines good","listText":"Vaccines good","text":"Vaccines good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120630914","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":120602136,"gmtCreate":1624320475825,"gmtModify":1703833270090,"author":{"id":"3578450583555005","authorId":"3578450583555005","name":"Jgoh","avatar":"https://static.tigerbbs.com/3cf0083e3d4efa2ebfc7f2fcefd8d99f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3578450583555005","authorIdStr":"3578450583555005"},"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/120602136","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4943923,"gmtCreate":1624320499764,"gmtModify":1663229662838,"authorId":3582660988760330,"author":{"id":3582660988760330,"idStr":"3582660988760330","authorId":3582660988760330,"name":"Trollingck","avatar":"https://static.tigerbbs.com/f85cee7a0dae1e53508cfcfe009a8823","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":120602136,"type":1,"supId":0,"prevId":0,"content":"h","text":"h","html":"h"},{"id":6343547,"gmtCreate":1635326720737,"gmtModify":1635326720771,"authorId":3578450583555005,"author":{"id":3578450583555005,"idStr":"3578450583555005","authorId":3578450583555005,"name":"Jgoh","avatar":"https://static.tigerbbs.com/3cf0083e3d4efa2ebfc7f2fcefd8d99f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":120602136,"type":1,"supId":0,"prevId":0,"content":"?","text":"?","html":"?"}],"langContent":"EN"},{"id":120608862,"gmtCreate":1624320432056,"gmtModify":1703833266349,"author":{"id":"3574970544772920","authorId":"3574970544772920","name":"peakaboo","avatar":"https://static.tigerbbs.com/0e48f646ead1b2a6b5e7b8c204d2b68c","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3574970544772920","authorIdStr":"3574970544772920"},"htmlText":"The world need vaccine&nbsp;","listText":"The world need vaccine&nbsp;","text":"The world need vaccine","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/120608862","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4945113,"gmtCreate":1624322833123,"gmtModify":1663229667653,"authorId":3582365143818595,"author":{"id":3582365143818595,"idStr":"3582365143818595","authorId":3582365143818595,"name":"Oddleo","avatar":"https://static.tigerbbs.com/569e40b38ccc6665e8895b488137078c","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":120608862,"type":1,"supId":0,"prevId":0,"content":"Yes You are right","text":"Yes You are right","html":"Yes You are right"}],"langContent":"EN"},{"id":120608190,"gmtCreate":1624320429610,"gmtModify":1703833266512,"author":{"id":"3583568085402852","authorId":"3583568085402852","name":"IsaacYap90","avatar":"https://static.tigerbbs.com/40f66d0266826bb209ee22688d7bbde5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3583568085402852","authorIdStr":"3583568085402852"},"htmlText":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.","listText":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.","text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120608190","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":120608058,"gmtCreate":1624320423074,"gmtModify":1703833266023,"author":{"id":"3582056608155770","authorId":"3582056608155770","name":"ckong2013","avatar":"https://static.tigerbbs.com/d8d6f85ffcd3fd73bb7bc85f85e9f0cf","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3582056608155770","authorIdStr":"3582056608155770"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/120608058","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4943875,"gmtCreate":1624320441942,"gmtModify":1663229661140,"authorId":3583568085402852,"author":{"id":3583568085402852,"idStr":"3583568085402852","authorId":3583568085402852,"name":"IsaacYap90","avatar":"https://static.tigerbbs.com/40f66d0266826bb209ee22688d7bbde5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":120608058,"type":1,"supId":0,"prevId":0,"content":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.","text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.","html":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots."}],"langContent":"EN"},{"id":120601405,"gmtCreate":1624320411307,"gmtModify":1703833265536,"author":{"id":"3585969981658298","authorId":"3585969981658298","name":"Claireeeee","avatar":"https://static.tigerbbs.com/8210c79a75f0858c29063909c70e422d","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3585969981658298","authorIdStr":"3585969981658298"},"htmlText":"haha","listText":"haha","text":"haha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/120601405","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4943882,"gmtCreate":1624320450407,"gmtModify":1663229659855,"authorId":3583568085402852,"author":{"id":3583568085402852,"idStr":"3583568085402852","authorId":3583568085402852,"name":"IsaacYap90","avatar":"https://static.tigerbbs.com/40f66d0266826bb209ee22688d7bbde5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":120601405,"type":1,"supId":0,"prevId":0,"content":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.","text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.","html":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots."}],"langContent":"EN"},{"id":120601114,"gmtCreate":1624320396038,"gmtModify":1703833269928,"author":{"id":"3575545273063583","authorId":"3575545273063583","name":"hobbitt","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3575545273063583","authorIdStr":"3575545273063583"},"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120601114","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":120609464,"gmtCreate":1624320356758,"gmtModify":1703833262926,"author":{"id":"3563253186452228","authorId":"3563253186452228","name":"Sheryl85","avatar":"https://static.tigerbbs.com/b7a9183a9332355f694e2f0af874b0ed","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":3,"crmLevelSwitch":0,"idStr":"3563253186452228","authorIdStr":"3563253186452228"},"htmlText":"wow","listText":"wow","text":"wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/120609464","repostId":2145031425,"repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4950562,"gmtCreate":1624338565901,"gmtModify":1663229698947,"authorId":3563253186452228,"author":{"id":3563253186452228,"idStr":"3563253186452228","authorId":3563253186452228,"name":"Sheryl85","avatar":"https://static.tigerbbs.com/b7a9183a9332355f694e2f0af874b0ed","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":120609464,"type":1,"supId":4949862,"prevId":0,"content":"[Cool]","text":"[Cool]","html":"[Cool]"},{"id":4950563,"gmtCreate":1624338573950,"gmtModify":1663229695630,"authorId":3563253186452228,"author":{"id":3563253186452228,"idStr":"3563253186452228","authorId":3563253186452228,"name":"Sheryl85","avatar":"https://static.tigerbbs.com/b7a9183a9332355f694e2f0af874b0ed","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":120609464,"type":1,"supId":4949456,"prevId":0,"content":"[Happy]","text":"[Happy]","html":"[Happy]"},{"id":4949456,"gmtCreate":1624334089407,"gmtModify":1663229687953,"authorId":3563150446821026,"author":{"id":3563150446821026,"idStr":"3563150446821026","authorId":3563150446821026,"name":"Acella","avatar":"https://static.tigerbbs.com/2712c4bb0bfbec4d2773e012189db3bc","vip":1,"crmLevel":9,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":120609464,"type":1,"supId":0,"prevId":0,"content":"?","text":"?","html":"?"},{"id":4949862,"gmtCreate":1624335749554,"gmtModify":1635252455450,"authorId":3570923041276809,"author":{"id":3570923041276809,"idStr":"3570923041276809","authorId":3570923041276809,"name":"potatochip","avatar":"https://static.tigerbbs.com/279b09d8c5dbf0fd92a959709ef9b5ff","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":120609464,"type":1,"supId":0,"prevId":0,"content":"Ohh [Serious]","text":"Ohh [Serious]","html":"Ohh [Serious]"},{"id":4964315,"gmtCreate":1624407119496,"gmtModify":1635251115804,"authorId":3560241002253187,"author":{"id":3560241002253187,"idStr":"3560241002253187","authorId":3560241002253187,"name":"CL777","avatar":"https://static.tigerbbs.com/e9aef3dd830373a0427a3447b1b564e3","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.09.20","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":120609464,"type":1,"supId":0,"prevId":0,"content":"Yea","text":"Yea","html":"Yea"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":217,"commentSize":55,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}